In addition, we used the bioinformatics analysis–based immune cell-specific signatures to examin the relationship between FCGBP expression with tumor-infiltrating immune cells and immune-related molecules, and drew further interest regarding whether FCGBP could act as a novel immune marker for immune therapy of glioma patients. This evidence concerns the gene FCGBP and central nervous system cancer.